45 studies found for:    " June 03, 2008":" July 03, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Completed Response to Standard HIV Treatment in Bamako, Mali
Condition: HIV Infections
Intervention:
22 Completed Durability of Nevirapine-Based Antiretroviral Regimen
Condition: HIV Infections
Intervention: Drug: nevirapine
23 Active, not recruiting Effectiveness of Antiretroviral Therapy During Acute HIV Infection
Condition: HIV Infections
Interventions: Drug: Highly Active Antiretroviral Therapy (HAART);   Other: No treatment
24 Completed Sleep Quality and Presence of Sleep Disordered Breathing
Conditions: HIV Infections;   Sleep
Intervention:
25 Completed Phase I Study of HIV Adenoviral Vector Vaccine in Healthy Subjects Using Needle or Biojector Injection
Condition: HIV Infections
Intervention: Drug: VRC-HIVADV014-00-VP
26 Completed VENICE Study Nevirapine Full Dose/Dose Escalation
Condition: HIV Infections
Intervention: Drug: nevirapine
27 Active, not recruiting Effectiveness of Communication Technology in Disseminating HIV Prevention Training to Non-governmental Organizations
Condition: HIV Infections
Interventions: Behavioral: Face-to-face training;   Behavioral: Distance training;   Behavioral: Popular Opinion Leader (POL)
28 Completed Effectiveness of an HIV Prevention Program That Targets the Inner Workings of High-risk Social Networks
Condition: HIV Infections
Interventions: Behavioral: Network leader training;   Behavioral: Standard HIV risk-reduction counseling
29 Completed Safety and Effectiveness of Tenofovir 1% Gel, Tenofovir Disproxil Fumarate, and Emtricitabine/Tenofovir Disoproxil Fumarate Tablets in Preventing HIV in Women
Condition: HIV Infections
Interventions: Drug: Emtricitabine/tenofovir disoproxil fumarate;   Drug: Emtricitabine/tenofovir disoproxil fumarate placebo;   Drug: Tenofovir disoproxil fumarate;   Drug: Tenofovir disoproxil fumarate placebo;   Drug: Tenofovir 1% vaginal gel;   Drug: Tenofovir placebo
30 Completed
Has Results
Kaletra-isentress Treatment Evaluation
Condition: HIV Infections
Interventions: Drug: Kaletra + Isentress;   Drug: Pre-study antiretroviral regimen
31 Completed Impact of an HPV Vaccine in HIV-Infected Young Women
Condition: HIV Infection
Intervention: Biological: HPV vaccine for strains -6, -11, -16, and -18
32 Completed GSK706769 Repeat Dose Study
Conditions: Healthy Subjects;   Infection, Human Immunodeficiency Virus
Intervention: Drug: GSK706769
33 Completed Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in HIV-positive Adults.
Condition: Tuberculosis (TB)
Interventions: Biological: GSK's candidate Mycobacterium tuberculosis vaccine 692342;   Biological: Control vaccine with the adjuvant system.;   Biological: Control vaccine with physiological saline
34 Completed Registry to Assess Long-term Outcome in HIV Subjects Who Participated in Phase 2 and 3 Clinical Trials Involving Vicriviroc (Study P04999)
Condition: HIV Infections
Interventions: Drug: Vicriviroc maleate;   Drug: Placebo;   Drug: Emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg
35 Withdrawn Directly Administered Antiretroviral Therapy (DAART) Among HIV-1infected Injecting Drug Users (IDUs) in Chennai, India
Conditions: HIV Infections;   Heroin Dependence
Interventions: Behavioral: Directly Administered Antiretroviral Therapy (DAART);   Behavioral: SAT
36 Completed Study of the Antiviral and Immunological Effects of Intensification of Suppressive Antiretroviral Therapy With Maraviroc
Condition: HIV Infections
Intervention: Drug: Maraviroc
37 Completed
Has Results
Immune Responses to Pneumococcal Vaccination Among HIV-infected Subjects
Condition: HIV Infections
Interventions: Biological: (PV) 23-valent pneumococcal polysaccharide vaccine;   Biological: Placebo
38 Completed Trial of Cognitive Behavioral Therapy to Reduce Antiretroviral Therapy Side Effects
Conditions: HIV Infections;   Adverse Effects
Intervention: Behavioral: Cognitive-behavioral therapy
39 Withdrawn Surveillance Cohort Long-Term Toxicity Antiretrovirals in HIV-Infected Patients Enrolled in TPV Cohort
Condition: HIV Infections
Intervention: Drug: Tipranavir
40 Completed
Has Results
Adding Maraviroc to Antiretroviral Therapy for Suboptimal CD4 T-Cell Recovery Despite Sustained Virologic Suppression
Condition: HIV Infections
Intervention: Drug: Maraviroc

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-45) Show next page of results    Last Page
Indicates status has not been verified in more than two years